PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. Miladzandi416@gmail.com.\', \'Research Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, Iran. Miladzandi416@gmail.com.\', \'Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.\', \'Research Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, Iran.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s11030-021-10272-w
?:hasPublicationType
?:journal
  • Molecular diversity
is ?:pmid of
?:pmid
?:pmid
  • 34241772
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.494
?:rankingScore_hIndex
  • 50
?:title
  • Hemagglutinin-esterase cannot be considered as a candidate for designing drug against COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34241772>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34241772>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all